Piracetam: Enhance Cognitive Function and Neuroprotection
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.15 (0%) | 🛒 Add to cart |
| 60 | $1.10 | $82.30 $66.24 (20%) | 🛒 Add to cart |
| 90 | $1.01 | $123.46 $91.34 (26%) | 🛒 Add to cart |
| 120 | $0.98 | $164.61 $117.43 (29%) | 🛒 Add to cart |
| 180 | $0.94 | $246.91 $168.62 (32%) | 🛒 Add to cart |
| 270 | $0.90 | $370.37 $243.90 (34%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $493.82 $318.18 (36%) | 🛒 Add to cart |
Synonyms | |||
Piracetam is a nootropic agent belonging to the racetam family, primarily indicated for cognitive enhancement and neuroprotective applications. As a cyclic derivative of gamma-aminobutyric acid (GABA), it modulates neurotransmitter systems without sedative or stimulant properties. Its mechanism involves improving neuronal membrane fluidity, enhancing cholinergic and glutamatergic transmission, and supporting cerebral metabolic activity. Clinically utilized for decades, piracetam is recognized for its favorable safety profile and evidence-based benefits in cognitive support.
Features
- Chemical name: 2-oxo-1-pyrrolidine acetamide
- Molecular formula: C₆H₁₀N₂O₂
- Molecular weight: 142.16 g/mol
- Appearance: White crystalline powder
- Solubility: Freely soluble in water
- Elimination half-life: Approximately 4–5 hours
- Administration: Oral, intravenous
Benefits
- Enhances learning capacity and memory consolidation through improved synaptic plasticity.
- Supports cognitive performance in age-related cognitive decline by optimizing cerebral metabolism.
- Provides neuroprotective effects against hypoxic and toxic insults via membrane stabilization.
- Improves neuronal communication by modulating acetylcholine and glutamate receptors.
- May reduce severity and frequency of cortical myoclonus through cortical hyperexcitability modulation.
- Supports functional recovery in post-stroke aphasia and related cerebrovascular conditions.
Common use
Piracetam is commonly prescribed for cognitive disorders, including age-associated memory impairment, mild cognitive impairment, and dyslexia-related learning difficulties. It is also used adjunctively in the management of cortical myoclonus, post-stroke aphasia, and vertigo of central origin. Off-label applications include support for cognitive function in neurodegenerative conditions and as a complementary agent in seizure disorders. Its use spans both geriatric and adult populations under medical supervision.
Dosage and direction
Standard initial dosage for cognitive support is 800 mg orally three times daily, titrated upward based on tolerance and clinical response. Maintenance doses typically range from 2.4–4.8 g/day, divided into 2–3 administrations. For cortical myoclonus, doses may reach 7.2–20 g/day under strict medical oversight. Administration with meals may reduce potential gastrointestinal discomfort. Dosage adjustments are necessary in renal impairment. Always follow prescribing clinician instructions.
Precautions
Use with caution in patients with bleeding disorders or those undergoing surgical procedures due to potential effects on platelet aggregation. Monitor renal function periodically during long-term therapy. Avoid abrupt discontinuation after prolonged use; taper gradually under medical guidance. Not recommended during pregnancy or lactation unless potential benefits outweigh risks. Use cautiously in patients with history of psychological disorders. Keep out of reach of children.
Contraindications
Hypersensitivity to piracetam or other pyrrolidone derivatives. Severe renal impairment (creatinine clearance <20 mL/min). Huntington’s chorea due to potential exacerbation of symptoms. Hemorrhagic diathesis or active bleeding disorders. Concomitant use with anticoagulants or antiplatelet agents without close monitoring. Not indicated for children under 16 years except in specific pediatric neurological conditions under specialist care.
Possible side effect
Common: nervousness, anxiety, weight gain, gastrointestinal discomfort, insomnia.
Less common: drowsiness, asthenia, depression, hyperkinesia, rash.
Rare: thrombophlebitis (with IV administration), exacerbation of epilepsy, severe hypersensitivity reactions.
Most side effects are dose-dependent and reversible upon dosage reduction or discontinuation.
Drug interaction
May potentiate effects of anticoagulants (e.g., warfarin) and antiplatelet drugs, increasing bleeding risk. Can enhance central effects of stimulants, antipsychotics, and antidepressants. Concomitant use with thyroid hormones may increase cognitive stimulation and agitation. Potential interaction with drugs affecting renal function. Monitor closely when used with other nootropic or psychotropic agents.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure stable plasma concentrations. Consult healthcare provider if multiple doses are missed or if uncertain about administration.
Overdose
Symptoms may include diarrhea, abdominal pain, nervousness, and insomnia. Severe overdose could potentially lead to pronounced neurological effects such as agitation or drowsiness. Management is supportive; there is no specific antidote. Gastric lavage may be considered if ingestion was recent. Hemodialysis can remove piracetam due to its low protein binding and water solubility. Seek immediate medical attention.
Storage
Store at room temperature (15–30°C) in a dry place protected from light. Keep container tightly closed. Do not freeze. Discard any unused medication after the expiration date. Do not store in bathroom or damp areas. Keep away from heat and open flame.
Disclaimer
This information is for educational purposes and does not constitute medical advice. Piracetam is a prescription medication in many jurisdictions. Always consult a qualified healthcare professional before use, especially if you have pre-existing medical conditions or are taking other medications. Not evaluated or approved for all uses mentioned; regulatory status varies by country.
Reviews
Clinical studies and meta-analyses generally support piracetam’s efficacy in cognitive enhancement and cortical myoclonus management, though results vary by population and dosage. User reports often highlight improved memory recall and mental clarity, though some note minimal effects at lower doses. Long-term users frequently report sustained benefits with few adverse effects when used as directed. Critical reviews emphasize the need for larger, randomized controlled trials in broader populations.